PHARMACOECONOMICAL EXPENDITURES IN PATIENTS WITH DIABETES MELLITUS; THE ROLE OF THE PHARMACIST IN CONSULTATION PROCESS

PHARMACOECONOMICAL EXPENDITURES IN PATIENTS WITH DIABETES MELLITUS; THE ROLE OF THE PHARMACIST IN CONSULTATION PROCESS

Authors

  • NATIA KVIZHINADZE
  • ANA DUGHASHVILI
  • NANA DUGHASHVILI
  • ZAZA PUTKARADZE

DOI:

https://doi.org/10.52340/jecm.2022.07.02

Keywords:

Diabetes mellitus, pharmacist, consultation

Abstract

Aim: The aim of the study is: determine the involvement of a pharmacist in the management of diabetes mellitus; calculate the economical expenditures during the management of the disease.

Methods: during the study modern opportunities were used and through a special questionnaire from google, contacted the respondents and collected the proper information.

Conclusion: Due to the fact that the out-of-pocket payment for medical care by the patient is very high, proper treatment of diabetics remains a significant challenge in the country. Most pharmacists are willing to be actively involved in the treatment of patients with diabetes and to better help them avoid possible complications. A large number of pharmacists recognize that their competence and scant information about the disease make it limited to provide full-fledged consultation to patients; The problem of financial accessibility for people with diabetes causes significant harm to the patient and hinders the proper management of the disease.

Downloads

Download data is not yet available.

References

Dall TM, Mann SE, Zhang Y, et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag. 2009;12:103–110.

Eknoyan G, Nagy J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv Chronic Kidney Dis. 2005;12:223-9.

Rosenfeld L. Insulin: discovery and controversy. Clin Chem. 2002; 48:2270-88.

Falta W BR. Insularer und insulinresistenter diabetes. Klin Wochenschr. 1931; 10:438-443.

Cudworth AG: The aetiology of diabetes mellitus. Br J Hosp Med. 1976; 16:207–216.

Himsworth HP: Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1936; 1:127–130.

Gale E.A. The discovery of type 1 diabetes. Diabetes. https://diabetes.diabetesjournals.org/content/50/2/217

2017 National Standards for diabetes. 2017 National Standards for Diabetes Self-Management Education and Support. American diabetes association, Diabetes Care. https://care.diabetesjournals.org/content/40/10/1409

Effectiveness of pharmacist’s 2018. Effectiveness of pharmacist's intervention in the management of cardiovascular diseases. https://pubmed.ncbi.nlm.nih.gov/29344376

Downloads

Published

2022-10-27

How to Cite

KVIZHINADZE, N. ., DUGHASHVILI, A. ., DUGHASHVILI, N. ., & PUTKARADZE, Z. . (2022). PHARMACOECONOMICAL EXPENDITURES IN PATIENTS WITH DIABETES MELLITUS; THE ROLE OF THE PHARMACIST IN CONSULTATION PROCESS . Experimental and Clinical Medicine Georgia, (7). https://doi.org/10.52340/jecm.2022.07.02

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

<< < 1 2 3 4 

You may also start an advanced similarity search for this article.

Loading...